During the past decade, East Coast Institute for Research, LLC conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 42 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 25 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Coast Institute for Research, LLC" #1 sponsor was "Eli Lilly and Company" with 12 trials, followed by "Boehringer Ingelheim" with 7 trials sponsored, "Pfizer" with 6 trials sponsored, "Shire" with 5 trials sponsored and "Akebia Therapeutics" with 5 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Coast Institute for Research, LLC" #1 collaborator was "Eli Lilly and Company" with 7 trials as a collaborator, "Cyclerion Therapeutics" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Canadian VIGOUR Centre" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "East Coast Institute for Research, LLC" are "Type 2 Diabetes Mellitus" (7 trials), "Type 2 Diabetes" (5 trials), "Crohn's Disease" (4 trials), "Heart Failure" (4 trials) and "Ulcerative Colitis" (4 trials). Many other conditions were trialed in "East Coast Institute for Research, LLC" in a lesser frequency.

Most popular intervention types in "East Coast Institute for Research, LLC" are "Drug" (47 trials), "Other" (11 trials), "Device" (8 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Empagliflozin" (6 trials), "Dulaglutide" (4 trials), "Insulin Degludec" (4 trials) and "Ontamalimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "East Coast Institute for Research, LLC" are 55 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "East Coast Institute for Research, LLC". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in East Coast Institute for Research, LLC, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in East Coast Institute for Research, LLC, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".